We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNeptune Wellness Solutions Inc.

Neptune Wellness Solutions Inc.

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
49999
Market Cap
0.00M

Momentum Score

…

Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally. It's product portfolio includes omega-3 fish oils and other nutritional products, as well as softgel solutions under the Biodroga brand; and provides MaxSimil, an omega-3 fatty acid delivery technology that uses enzymes to predigest omega-3 fatty acids. The company offers vegan multi-omega gummies and soft gels under the Forest Remedies brand; and organic baby food products under the Sprout brands. It offers its products through distributors, retail outlets, and grocery stores, as well as online on forestremedies.com and sproutorganics.com, and e-commerce sites. Neptune Wellness Solutions Inc. was incorporated in 1998 and is headquartered in Laval, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.03
High
52 Week Price Range
0.00
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
39.11M
Revenue Per Share
26.87
Gross Profit TTM
-0.76M
Debt / Equity
-2.12
ROE
-
Net Debt
23.32M
ROCE
856.92%
Diluted EPS TTM
-8064.11

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -88.80M -88.80M -84.42M -127.74M -39.67M
Minority interest - 28.34M 9.45M 1.09M 0.00M
Net income -60.46M -60.46M -74.97M -123.17M -42.92M
Selling general administrative - 46.42M 60.54M 63.82M 45.60M
Gross profit -2.47M -2.47M -7.54M -27.37M -1.30M
Reconciled depreciation - 2.73M 6.08M 19.06M 5.91M
Ebit -86.60M - - - -
Ebitda -83.87M - - - -
Depreciation and amortization 2.73M - - - -
Operating income -102.85M -49.38M -68.95M -93.12M -48.92M
Other operating expenses 155.46M - - - -
Interest expense 2.32M 2.20M 1.54M 0.92M 0.41M
Tax provision - 0.00M 0.00M -3.48M 3.24M
Interest income - 0.00M 0.01M 0.04M 0.11M
Net interest income - -2.32M -1.53M -0.09M -0.30M
Total revenue 52.62M 52.62M 48.80M 35.40M 20.86M
Total operating expenses 100.37M 102.00M 117.75M 128.52M 69.77M
Cost of revenue 55.09M 55.09M 56.33M 62.77M 22.15M
Total other income expense net 14.05M -37.10M -13.94M -34.53M 9.55M
Net income from continuing ops - -88.80M -84.42M -124.26M -42.92M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 30.93M 30.93M 104.95M 186.95M 119.01M
Intangible assets 1.61M 1.61M 21.66M 25.96M 17.99M
Other current assets 1.03M - - - -
Total liab 58.49M 58.49M 44.12M 49.40M 17.73M
Total stockholder equity -11.94M -11.94M 48.12M 115.37M 101.28M
Other current liab 12.63M 3.16M 5.57M 10.46M -
Common stock 321.95M - - - -
Capital stock - 321.95M 317.05M 306.62M 150.81M
Retained earnings -383.64M -383.64M -323.18M -248.21M -115.31M
Good will 2.43M 2.43M 22.17M 25.45M 29.85M
Cash 1.99M 1.99M 8.73M 59.84M 11.69M
Total current liabilities 41.03M 41.03M 30.32M 34.81M 12.14M
Net debt 23.32M 20.96M 2.92M - -
Short term debt 7.88M - - - -
Short long term debt - 7.54M - - 2.24M
Short long term debt total 25.31M - - - -
Other stockholder equity 64.29M - - - -
Total current assets 23.55M 23.55M 37.39M 89.53M 27.36M
Long term investments - - 0.00M 5.77M 0.37M
Short term investments 0.02M 0.02M 0.02M 0.02M 0.03M
Net receivables 7.51M 5.70M 6.99M 6.10M 6.23M
Long term debt - 15.41M 11.65M 11.31M -
Inventory 13.01M 13.01M 17.06M 17.32M 6.41M
Accounts payable 20.53M 20.53M 10.67M 12.15M 3.64M
Accumulated other comprehensive income -14.54M - - - -
Non current assets total 7.38M 7.38M 67.57M 97.42M 91.65M
Capital lease obligations - 2.36M 2.71M 3.12M 1.12M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments - 2.36M -2.33M -10.12M -17.31M
Total cashflows from investing activities 2.36M - - - -
Total cash from financing activities 19.29M 19.29M 5.95M 115.00M 44.08M
Net income -60.46M -60.46M -74.97M -167.15M -60.86M
Change in cash -6.73M -6.73M -51.11M 48.05M 4.77M
Begin period cash flow 8.73M 8.73M 59.84M 11.79M 6.92M
End period cash flow 1.99M 1.99M 8.73M 59.84M 11.69M
Total cash from operating activities -28.57M -28.57M -54.35M -56.65M -22.16M
Issuance of capital stock - 11.00M 8.00M 116.87M 43.04M
Depreciation 2.73M 2.73M 6.08M 19.06M 5.91M
Other cashflows from investing activities 3.29M - - - -
Dividends paid - - - 0.00M 0.00M
Change to inventory -2.02M -2.02M -2.67M -17.63M -3.34M
Change to account receivables -1.61M - - - -
Other cashflows from financing activities -2.08M - - - -
Capital expenditures 0.93M 0.93M 2.37M 7.01M 10.06M
Change in working capital 7.76M 7.76M -3.16M -13.81M -6.19M
Stock based compensation 3.50M 3.50M 7.82M 9.89M 11.70M
Other non cash items 17.90M 4.28M 2.14M 0.94M -69.58M
Free cash flow -29.50M -29.50M -56.72M -63.65M -32.23M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NEPTF
Neptune Wellness Solutions Inc.		 -
-%		 0.00 - - - 0.56 0.69 -0.25
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Neptune Wellness Solutions Inc.

Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally. It's product portfolio includes omega-3 fish oils and other nutritional products, as well as softgel solutions under the Biodroga brand; and provides MaxSimil, an omega-3 fatty acid delivery technology that uses enzymes to predigest omega-3 fatty acids. The company offers vegan multi-omega gummies and soft gels under the Forest Remedies brand; and organic baby food products under the Sprout brands. It offers its products through distributors, retail outlets, and grocery stores, as well as online on forestremedies.com and sproutorganics.com, and e-commerce sites. Neptune Wellness Solutions Inc. was incorporated in 1998 and is headquartered in Laval, Canada.

545 Promenade du Centropolis, Laval, QC, Canada, H7T 0A3

450 687 2262

https://www.neptunecorp.com

50

Name Title Year Born
Mr. Michael A. de Geus CEO, Interim President & Director 1978
Mr. John S. Wirt CLO, EVP of Legal & Business Affairs and General Counsel(Leave of Absence) 1963
Ms. Lisa H. Gainsborg CPA Interim Chief Financial Officer 1967
Mr. Cedrick Billequey Interim Chief Operating Officer NA
Ms. Melody Harwood Head of Scientific & Regulatory Affairs for Cannabis Business NA
Mr. Scott Antony Senior Vice President of U.S. Retail Sales NA
Mr. Christopher Piazza Acting General Counsel & Assistant Corporate Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…